1-2 of 2
Keywords: Augmentation therapy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Partial Response at Week 4 Can Predict Subsequent Outcome during Lamotrigine Augmentation Therapy in Treatment-Resistant Depressive Disorder: A Preliminary Study

Subject Area:
Neurology and Neuroscience , Psychiatry and Psychology
Goyo Nagai, Kazuo Mihara, Shoko Kagawa, Akifumi Nakamura, Takeshi Suzuki, Kenji Nemoto, Tsuyoshi Kondo
Journal: Neuropsychobiology
Neuropsychobiology (2018) 76 (4): 187–192.
https://doi.org/10.1159/000489967
Published Online: 29 June 2018
...Goyo Nagai; Kazuo Mihara; Shoko Kagawa; Akifumi Nakamura; Takeshi Suzuki; Kenji Nemoto; Tsuyoshi Kondo Background/Aims: The present study prospectively examined whether or not a partial response at week 4 predicts subsequent response at week 8 during lamotrigine augmentation therapy in 51 (16 males...
View articletitled, A Partial Response at Week 4 Can Predict Subsequent Outcome during Lamotrigine Augmentation Therapy in Treatment-Resistant Depressive Disorder: A Preliminary Study
Open the PDF for A Partial Response at Week 4 Can Predict Subsequent Outcome during Lamotrigine Augmentation Therapy in Treatment-Resistant Depressive Disorder: A Preliminary Study in another window
Journal Articles

Both Serum Brain-Derived Neurotrophic Factor and Interleukin-6 Levels Are Not Associated with Therapeutic Response to Lamotrigine Augmentation Therapy in Treatment-Resistant Depressive Disorder

Subject Area:
Neurology and Neuroscience , Psychiatry and Psychology
Shoko Kagawa, Kazuo Mihara, Takeshi Suzuki, Goyo Nagai, Akifumi Nakamura, Kenji Nemoto, Tsuyoshi Kondo
Journal: Neuropsychobiology
Neuropsychobiology (2018) 75 (3): 145–150.
https://doi.org/10.1159/000484665
Published Online: 12 January 2018
... improvement in MADRS scores in the overall subjects. Conclusion: The present study suggests that the acute effect of lamotrigine augmentation therapy for a major depressive episode is not related to either BDNF or IL-6, at least in patients with treatment-resistant depressive disorder. 2 06 2017 24...
View articletitled, Both Serum Brain-Derived Neurotrophic Factor and Interleukin-6 Levels Are Not Associated with Therapeutic Response to Lamotrigine Augmentation Therapy in Treatment-Resistant Depressive Disorder
Open the PDF for Both Serum Brain-Derived Neurotrophic Factor and Interleukin-6 Levels Are Not Associated with Therapeutic Response to Lamotrigine Augmentation Therapy in Treatment-Resistant Depressive Disorder in another window